课题基金 / 基金详情

Development of therapeutic strategy for allergic diseases based on the genome information

Development of therapeutic strategy for allergic diseases based on the genome information
基于基因组信息开发过敏性疾病治疗策略
批准号:
17390293
负责人:
KUBO Masato
金额:
$9.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KUBO Masato的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
From our previous study, the expression of IL-4 gene is found to be epigenetically regulated in CD4^+ T cells. However, these gene regulation mechanisms are virtually unclear. Therefore, we investigated the role of an evolutionarily conserved 〜200bp non-coding sequence in the intergenic region between IL-4 and KIF3 genes using GFP reporter transgenic (Tg) mice. Notch signals have been shown to affect the cellular differentiation of tissue throughout the life of multicellular organisms. RBP-Jκ is a downstream common transcriptional mediator in Notch signaling. The T cell specific deficiency of RBP-J□ resulted in selective loss of Th2 development. Distal 3' enhancer in Il4 locus that correlates with the conserved regions called, Conserved non-coding sequences (CNS)-2, contained multiple possible binding sites for RBP-Jκ. Using a transgenic GFP reporter system, we showed that binding of RBP-Jκ to the CNS-2 enhancer regulated initial IL-4 production from NKT cells and a subset of CD44^<hi> memory phenotype (MP) CD4 T cells. The Rbp-j deficient T cells exhibited marked reduction of both CNS-2 enhancer activity and initial IL-4 from NKT and MP CD4 T cells. Depletion of CNS-2 active CD4 T cells markedly decreased Th2 differentiation from naive CD4 T cells. These results indicate the functional importance of Notch signal and MP CD4 T cells in facilitating Th2 differentiation of naive CD4 T cells during initial stage of antigen induced allergic responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
自然免疫と獲得免疫の基礎:Th1/Th2バランスと感染防御
先天免疫和获得性免疫的基础知识:Th1/Th2 平衡和感染防御
DOI: --
发表时间: 2005
期刊: 最新医学 60
影响因子: --
作者: [小林 桂子, 森田 明理, 久保 允人]
通讯作者: 久保 允人
Th1/Th2細胞の発見、そして制御機構の解明へ
Th1/Th2 细胞的发现及其控制机制的阐明
DOI: --
发表时间: 2005
期刊: Th1/Th2細胞の発見、そして制御機構の解明へ 8
影响因子: --
作者: [Kubo, M., et al., 久保 允人]
通讯作者: 久保 允人
SOCSとTh1/Th2分化とアレルギー炎症の制御
SOCS与Th1/Th2的分化及过敏性炎症的调节
DOI: --
发表时间: 2005
期刊: 炎症・再生 25
影响因子: --
作者: [小林 桂子, 森田 明理, 久保 允人, 森田 明理, 久保 允人]
通讯作者: 久保 允人
The role of IL-7/STAT5 pathway and suppressor of cytokine signaling 1 in maintenance of naive and memory CD4 T cells in peripheral lymphoid organs
IL-7/STAT5 通路和细胞因子信号传导抑制因子 1 在维持外周淋巴器官中幼稚和记忆 CD4 T 细胞中的作用
DOI: --
发表时间: 2007
期刊: J. Immunol. 1;178(1)
影响因子: --
作者: [Seki, Y., Yang, J., Okamoto, M., Tanaka, S., Goizuka, Farrar, M.A., R., and Kubo, M.]
通讯作者: M.
12
    Analysis of cytokines behavior in allergic disorder using in vivo imaging system
    • 批准号:
      24249058
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.37万
    • 财政年份:
      2012
    • 负责人:
      KUBO Masato
    • 依托单位:
    Understanding regulation of allergy by human single mutation using knock-in mouse line replacing with atopic type of human sequence
    • 批准号:
      23659243
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      KUBO Masato
    • 依托单位:
    Genomics based approach for allergic disorderand development of innovative therapeutic strategy
    • 批准号:
      21390302
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      KUBO Masato
    • 依托单位:
    Development of second generation therapeutic strategy based on genome information
    海外基金